We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The review of the safety of isotretinoin has concluded.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
How to submit your periodic safety update report report (PSUR) or periodic benefit risk evaluation report (PBRER)
Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS.
Product Safety Report for El Paradis Cosmetic Nature Secrete A L'Huile D'Argan presenting a serious chemical risk.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Check for listed disinfectants for aquaculture; or apply to have your product listed.
Product Safety Report for Purec Egyptian Magic Whitening Face and Body Lotion presenting a serious chemical risk due to the presence of hydroquinone and glucocorticoids.
Product Safety Report for PTS Packers and Providers Pvt Surfaz-SN Triple Action Cream presenting a serious chemical risk.
Product Safety Report for Uniparco Pure White Cosmetics Gold Glowing presenting a serious chemical risk.
Product Safety Report for Anise Shealight Fading Cream Face & Body presenting a serious chemical risk.
Product Safety Report for Super Eclaircissant White Absolute, Skin Whitening Cream presenting a serious chemical risk.
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
Product Safety Report for Fair & White So White skin lightening cream presenting a serious chemical risk due to the presence of hydroquinone.
Exeltis UK Limited has informed the MHRA regarding an inconsistency in the Patient Information Leaflet (PIL) packaged in cartons of the specified batches of Gepretix 100mg capsules.
Product batch recall alert for Purevax® RCP, Purevax® RCP FeLV and Eurican Herpes 205.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).